BSESupha Pharmachem LtdMinimalNeutral
Announced Mon, 7 Apr · 17:56 IST

Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2025.

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Remedium Lifecare Ltd has submitted a compliance certificate under SEBI Regulation 74(5) for the quarter ended March 31, 2025. The certificate was issued by Bigshare Services Private Limited, the company's Registrar and Share Transfer Agent. It confirms that no dematerialisation requests (requests to convert physical share certificates into electronic/demat form) were received from shareholders during the period January 1, 2025 to March 31, 2025. This is a routine quarterly compliance requirement for listed companies to confirm proper handling of share-related requests by their RTA.

Likely market impact

This is a routine procedural filing with no material impact on the company's financials, operations, or share price. Investors do not need to take any action — it simply confirms there were no demat conversion requests during the quarter.